Raquel González Villén

Dr. Raquel González Villén

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
LGLaura Garre-Morata
Laura Garre-Morata
THTomás de Haro
Tomás de Haro
RVRaquel González Villén
Raquel González Villén
LFLuisa Fernández-López
Luisa Fernández-López
Germaine EscamesGermaine Escames
Germaine Escames
Dario Acuña-CastroviejoDario Acuña-Castroviejo
Dario Acuña-Castroviejo
Although ADHD is one of the most prevalent diseases during childhood, we still do not know its precise origin; oxidative/nitrosative stress and the hypothalamic–pituitary–adrenal axis are suggested contributors. Methylphenidate, among others, is the main drug used in ADHD patients, but its effects on relevant markers and structures remain unclear. This study, involving 59 patients diagnosed with ADHD according to DSM-5 criteria, aimed to assess changes in cortisol levels (using cortisol awakening response, CAR) and oxidative/nitrosative status with the treatment. Blood samples before and 3 months after treatment with methylphenidate were used to measure oxidative and inflammatory markers, as well as the endogenous antioxidant activity, while saliva samples tracked cortisol awakening response (CAR). The results showed a treatment-related improvement in the redox profile, with the reduction in advanced oxidation protein products (AOPP), lipid peroxidation (LPO), and nitrite plus nitrate (NOx) levels, and the increase in the enzymatic activities of glutathione reductase (GRd) and catalase (CAT). Moreover, the area under the curve (AUC) of CAR increased significantly, indicating increased reactivity of the HPA axis. These results support, for the first time, the involvement of the endogenous antioxidant system in the pathophysiology of ADHD.

9 August 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
RVRaquel González Villén
Raquel González Villén
LFLuisa Fernández-López
Luisa Fernández-López
Ana Checa-RosAna Checa-Ros
Ana Checa-Ros
MPMaría Pilar Tortosa Pinto
María Pilar Tortosa Pinto
RRRaquel Aguado Rivas
Raquel Aguado Rivas
AMAntonio Molina-Carballo
Antonio Molina-Carballo
Inflammatory cytokines are involved in attention deficit hyperactivity disorder (ADHD), a highly prevalent neurodevelopmental disorder. To quantify the baseline levels of pro- and anti-inflammatory cytokines and their changes after methylphenidate (MPH), a total of 31 prepubertal children with ADHD were recruited and subclassified into only two ADHD presentations—ADHD attention deficit (n = 13) or ADHD combined (n = 18). The children were also screened for oppositional defiant conduct disorder (ODCD) and anxiety disorder. Blood samples were drawn at 09:00 and after 4.63 ± 1.87 months of treatment. Four pro-inflammatory cytokines (interleukin-1beta (IL-1β), IL-5, IL-6, tumor necrosis factor-alpha (TNF-α)) and three anti-inflammatory cytokines (IL-4, IL-10, IL-13) were measured using a Luminex® assay. For statistics, a factorial analysis was performed in Stata 15.1. Overall, there were no statistically significant differences in the interleukin (IL) values induced by treatment. When grouped by presentation, the differences were present almost exclusively in ADHD-AD, usually with a profile opposite to that observed in ADHD-C, and with interactions between comorbid factors, with IL-1β (p = 0.01) and IL-13 (p = 0.006) being the ones reaching the greatest statistical significance. These differences are probably related to the ODCD factor, and they disappear after treatment. In conclusion, the changes observed in cytokine levels in prepubertal children only in the ADHD-AD presentation are probably related to comorbidities (specifically ODCD) and are mitigated after treatment.

1 April 2021 in Anales de Pediatría
Verified
Journal Article
Open access
RVRaquel González Villén
Raquel González Villén
ICIrene Sofía Machado Casas
Irene Sofía Machado Casas
SLSusana García Linares
Susana García Linares
JVJosé María Gómez Vida
José María Gómez Vida

3 August 2021 in Revista Colombiana de Medicina Física y Rehabilitación
Verified
Journal Article
Open access
PDF file
ACAntonio Carmona-Espejo
Antonio Carmona-Espejo
RVRaquel González Villén
Raquel González Villén
La terapia ocupacional supone un aspecto fundamental en la rehabilitación de cualquier paciente ingresado en una unidad hospitalaria; su uso ha demostrado aportar grandes beneficios en la recuperación de los pacientes y en su adaptación a la vida cotidiana. Entre estas actividades se encuentra la alimentación, por lo que el tratamiento de la disfagia supone un pilar fundamental en el restablecimiento de las actividades básicas de la vida diaria.

1 December 2019 in Revista Colombiana de Medicina Física y Rehabilitación
Verified
Journal Article
Open access
PDF file
ACAntonio Carmona-Espejo
Antonio Carmona-Espejo
RVRaquel González Villén
Raquel González Villén
En la actualidad, la discapacidad supone una cuestión socioeconómica difícil de abordar en todo su espectro. Se estima que en España el 6,1% de la población sufre algún tipo de discapacidad; sin embargo, según la Organización Mundial de la Salud, esta cifra es de alrede- dor del 15% a nivel mundial. En este sentido, es prioritario lograr un adecuado equilibrio que proporcione recursos económicos y sociales a este sector poblacional y que garantice su inte- gración social de manera completa y equitativa.

24 July 2020 in Revista Colombiana de Medicina Física y Rehabilitación
Verified
Journal Article
Open access
PDF file
ACAntonio Carmona-Espejo
Antonio Carmona-Espejo
RVRaquel González Villén
Raquel González Villén
Movilidad precoz de pacientes Covid-19 en unidad de cuidados intensivos